Development of an in vivo cleavable donor plasmid for targeted transgene integration by CRISPR-Cas9 and CRISPR-Cas12a
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Development of an in vivo cleavable donor plasmid for targeted transgene integration by CRISPR-Cas9 and CRISPR-Cas12a ; volume:12 ; number:1 ; day:22 ; month:10 ; year:2022 ; pages:1-12 ; date:12.2022
Scientific reports ; 12, Heft 1 (22.10.2022), 1-12, 12.2022
- Urheber
-
Ishibashi, Riki
Maki, Ritsuko
Kitano, Satsuki
Miyachi, Hitoshi
Toyoshima, Fumiko
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-022-22639-6
- URN
-
urn:nbn:de:101:1-2023010621041561685154
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:37 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Ishibashi, Riki
- Maki, Ritsuko
- Kitano, Satsuki
- Miyachi, Hitoshi
- Toyoshima, Fumiko
- SpringerLink (Online service)
Ähnliche Objekte (12)
Ratiometric nonfluorescent CRISPR assay utilizing Cas12a-induced plasmid supercoil relaxation
Gene targeting in adult organs using in vivo cleavable donor plasmids for CRISPR-Cas9 and CRISPR-Cas12a
CRISPR-Cas12a-assisted nucleic acid detection
Programmable RNA detection with CRISPR-Cas12a
Fabrication and characterization of PLGA nanoparticles encapsulating large CRISPR–Cas9 plasmid
A versatile one-step CRISPR-Cas9 based approach to plasmid-curing
CRISPR/Cas9 in Gastrointestinal Malignancies
CRISPR-Cas9 and T cells
Genome editing with TALEN, CRISPR-Cas9 and CRISPR-Cas12a in combination with AAV6 homology donor restores T cell function for XLP
Exploiting anti-CRISPR proteins for conditional activation of CRISPR-Cas9
Improving CRISPR–Cas9 directed faithful transgene integration outcomes by reducing unwanted random DNA integration
CRISPR-Cas12a-assisted gene tagging in mammalian cells
Ratiometric nonfluorescent CRISPR assay utilizing Cas12a-induced plasmid supercoil relaxation
Gene targeting in adult organs using in vivo cleavable donor plasmids for CRISPR-Cas9 and CRISPR-Cas12a
CRISPR-Cas12a-assisted nucleic acid detection
Programmable RNA detection with CRISPR-Cas12a
Fabrication and characterization of PLGA nanoparticles encapsulating large CRISPR–Cas9 plasmid
A versatile one-step CRISPR-Cas9 based approach to plasmid-curing
CRISPR/Cas9 in Gastrointestinal Malignancies
CRISPR-Cas9 and T cells
Genome editing with TALEN, CRISPR-Cas9 and CRISPR-Cas12a in combination with AAV6 homology donor restores T cell function for XLP
Exploiting anti-CRISPR proteins for conditional activation of CRISPR-Cas9
Improving CRISPR–Cas9 directed faithful transgene integration outcomes by reducing unwanted random DNA integration
CRISPR-Cas12a-assisted gene tagging in mammalian cells
Ratiometric nonfluorescent CRISPR assay utilizing Cas12a-induced plasmid supercoil relaxation
Gene targeting in adult organs using in vivo cleavable donor plasmids for CRISPR-Cas9 and CRISPR-Cas12a
CRISPR-Cas12a-assisted nucleic acid detection
Programmable RNA detection with CRISPR-Cas12a
Fabrication and characterization of PLGA nanoparticles encapsulating large CRISPR–Cas9 plasmid
A versatile one-step CRISPR-Cas9 based approach to plasmid-curing
CRISPR/Cas9 in Gastrointestinal Malignancies
CRISPR-Cas9 and T cells
Genome editing with TALEN, CRISPR-Cas9 and CRISPR-Cas12a in combination with AAV6 homology donor restores T cell function for XLP
Exploiting anti-CRISPR proteins for conditional activation of CRISPR-Cas9
Improving CRISPR–Cas9 directed faithful transgene integration outcomes by reducing unwanted random DNA integration